The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

Now in its third year, the trial is led by The Wistar Institute in collaboration with INOVIO, AstraZeneca, and clinical investigators at the University of Pennsylvania. It is funded by the Coronavirus ...

Patients with rosacea and skin of color are more likely to have severe disease phenotypes when compared with White patients with rosacea.

Your skin holds vital clues about your health. From thyroid issues to heart problems, discover what your skin is trying to ...

India: A recent case report published in the Cureus Journal has highlighted the effectiveness of liquid nitrogen cryotherapy ...

Crohn’s disease can cause digestive issues However since it is an inflammatory disease the symptoms can go beyond the gut ...

Diagnosis of PDB is a combination of clinical evaluation, imaging and histopathological assessment. If an underlying cancer ...

When a 60-year-old woman with severe abdominal pain shows positive Carnett’s and pinch signs, physicians suspect ACNES — but ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

The antibody tests available in the Netherlands are reliable, according to this doctoral research. However, it is important to test only in case of symptoms specific for Lyme disease and a real chance ...

Arcutis Biotherapeutics (ARQT) announced new data from two posters shared at the 2025 American Academy of Dermatology Annual Meeting, AAD. The ...

According to Huynh, covering as much of the skin as possible when outdoors is the best defense against tick bites. However, ...